2018 Highlights

Last Year at Life Sciences Future:

LSF 2018:


 

Schedule Highlights

Company Reverse Pitch Presentations
OraSure Technologies
DSM
B.Braun
Merck
DePuy Synthes
Globus Medical
Johnson & Johnson Innovation
Pfizer
Spark Therapeutics
Teleflex

Company Presentations
Isoma
Socium Therapeutics
Aro Biotherapeutics
Ariel Precision Medicine
AmorSui
viCardia Therapeutics
Carmell Therapeutics
Prolifagen
Face2Face Health
Atrin Pharmaceuticals
BioMagnetic Solutions
Thermaquil
Polyaurum
WindMIL Therapeutics
PepVax

Funding Meet-ups
1315 Capital
RobinHood Ventures
Binational Industrial Research and Development (BIRD) Foundation
BioAdvance
WI Harper Group
Paragon Biosciences
Capgenic Advisors
Citi Bank
Pittsburgh Life Sciences Greenhouse
Catalyze
New Rhein
Ben Franklin Technology Partners of SE PA
F Prime Capital Partners
Haitong
Johnson & Johnson Innovation
Delaware Crossing Investor Group
LifeX
BioMotiv

LSF Testimonials

“The sessions were outstanding and much appreciated by the faculty, administrators, and students who attended.”

– Dr. Helen F. Giles-Gee President,University of the Sciences

Life Sciences Future was one of the most productive, informative and educational events I have been to in a while. The format and content of the conference was spot-on.”

– Marc S. Malandro Ph.D., Associate Vice Chancellor for Technology Management and Commercialization, University of Pittsburgh

Life Sciences Future was a fantastic opportunity to meet with a wide range of contacts and potential partners in the Pennsylvania Life Sciences industry. We look forward to continuing to benefit from the great networking opportunities afforded by Life Sciences PA.”

-Kevin Elliott, IDA Ireland

“The location, the layout, the right mix of people and the timing were all well thought out. I thought the conference was great.”

– Rudy Treichel, Director of Graduate Programs, Widener University

“I found the Life Sciences Future Partnering System extremely beneficial and useful organizing more than 9 meetings with life science professionals throughout the day. Equally was outstanding the support from the Life Sciences PA team.”

– Renay A Ebelle, President & CEO, Ebelle D’Ebelle Pharmaceuticals, Inc.